Intel shares plunged more than 10% Tuesday to close at $116.405, marking the stock’s largest single-day drop in months and erasing a significant chunk of its recent AI-fueled gains. The selloff puts Intel’s market capitalization at $585.1 billion, reflecting growing investor unease with lofty valuations in the semiconductor sector.
The decline represents a sharp reversal for the chipmaker, which had been a standout performer. "Intel's elevated sales multiple suggests now is a good time to sell," wrote one analyst recently, capturing a growing sentiment that the stock's historic run had made it vulnerable to a pullback.
The numbers behind the reversal are stark. Before Tuesday's drop, Intel stock had soared more than 300% over the past 12 months and jumped 115% in April alone, according to WebSearch Result [3]. The rally was powered by a string of positive news, including an $8.9 billion federal investment, a deal to produce chips for Apple, and a strategic partnership in the Elon Musk-backed Terafab project. However, the decline occurred amid a wider market retreat, with the tech-heavy Nasdaq Composite falling 0.89% after a hot inflation report.
For investors, the key question is whether this is a temporary correction or a more fundamental re-rating of the stock. Intel’s price-to-sales ratio had reached levels not seen since the early 2000s, a valuation that assumed flawless execution on its turnaround strategy and its ambitious expansion into new markets. The company's high beta of nearly 1.4 signals a volatility that can cut both ways.
The turnaround story, led by CEO Lip-Bu Tan since 2025, has been built on regaining manufacturing leadership and capitalizing on the AI boom, where it competes with giants like Nvidia. While its role in the Terafab project remains a significant long-term opportunity, Tuesday's selloff shows that in the current market, even promising growth stories are being scrutinized under a lens of valuation discipline, especially when faced with macroeconomic headwinds like persistent inflation.
This article is for informational purposes only and does not constitute investment advice.
